GLP-1s Made Up Eight Of Every 100 Prescriptions Filled in March 2026

In a shift that is redefining the landscape of modern pharmacy, nearly 8 out of every 100 prescriptions filled in March 2026 were for glucagon-like peptide-1 (GLP-1) receptor agonists. This milestone follows the largest quarter-over-quarter percentage point increase in GLP-1 RA prescribing observed since tracking began in 2019. For pharmacists on the front lines, these numbers reflect a massive acceleration in patient demand that continues to test the limits of supply chains and clinical management.